Page last updated: 2024-08-26

combretastatin and Triple Negative Breast Neoplasms

combretastatin has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alain, T; Chambers, J; Côté, M; Cui, J; D'Costa, VM; Ekker, M; El-Sahli, S; Farah, E; Gadde, S; Hua, K; Lee, SH; Li, L; Li, X; Liu, D; McGarry, S; Sulaiman, A; Wang, L; Zheng, P	1

Other Studies

1 other study(ies) available for combretastatin and Triple Negative Breast Neoplasms

Article	Year
A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature. Cell death & disease, 2021, 01-04, Volume: 12, Issue:1 Topics: Animals; Apoptosis; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Combinations; Female; Humans; Mice, Nude; Nanoparticles; Neoplastic Stem Cells; Paclitaxel; Rats; Triple Negative Breast Neoplasms; Verteporfin; Zebrafish	2021

Article

Year

A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature.

Cell death & disease, 2021, 01-04, Volume: 12, Issue:1

Topics: Animals; Apoptosis; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Combinations; Female; Humans; Mice, Nude; Nanoparticles; Neoplastic Stem Cells; Paclitaxel; Rats; Triple Negative Breast Neoplasms; Verteporfin; Zebrafish

2021